MedPath

Deborah Gentile

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

Phase 4
Completed
Conditions
Upper Respiratory Infection
Interventions
Drug: Placebo
Drug: Montelukast
First Posted Date
2005-09-19
Last Posted Date
2020-11-18
Lead Sponsor
Deborah Gentile
Target Recruit Count
84
Registration Number
NCT00189475
Locations
🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children

Phase 4
Completed
Conditions
Otitis Media
Ear Infection
Acute Otitis Media
Interventions
Drug: Placebo
Drug: Montelukast
First Posted Date
2005-09-19
Last Posted Date
2020-11-18
Lead Sponsor
Deborah Gentile
Target Recruit Count
99
Registration Number
NCT00189462
Locations
🇺🇸

Bellevue Pediatric Associates, Bellevue, Pennsylvania, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Usual care (albuterol with or without oral steroid)
Drug: Nebulized Budesonide
First Posted Date
2005-09-19
Last Posted Date
2021-02-01
Lead Sponsor
Deborah Gentile
Target Recruit Count
61
Registration Number
NCT00189436
Locations
🇺🇸

Bellevue Pediatric Associates, Bellevue, Pennsylvania, United States

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath